Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316)

JOURNAL ARTICLE published December 2018 in BMC Cancer

Authors: Motoko Tachihara | Shunichi Negoro | Takako Inoue | Motohiro Tamiya | Yuki Akazawa | Takeshi Uenami | Yoshiko Urata | Yoshihiro Hattori | Akito Hata | Nobuyuki Katakami | Soichiro Yokota